Literature DB >> 21050301

Trends in the surgical treatment of breast cancer.

Monica Morrow1.   

Abstract

Here, we review the relationship between local recurrence (LR) and disease burden, biology, and targeted therapy. There is still little consensus on what constitutes an adequate margin for breast-conserving surgery, and it is not clear that margins more widely clear than tumor not touching ink decrease LR further. It is important to recognize that clear margins do not indicate the absence of microscopic tumor in the breast and that differences in margin width of a few millimeters do not alter the rates of LR. The molecular subtype of cancer is a powerful predictor of both distant and local relapse risk. Effective systemic therapy, targeted therapy in particular, significantly decreases LR. It is extremely unlikely that there is one margin width that is appropriate for all patients with breast cancer. Further progress in the individualization of local therapy requires a move beyond the fixation on disease burden and the recognition that extent of local therapy should be tailored to tumor biology.
© 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21050301     DOI: 10.1111/j.1524-4741.2010.00996.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  3 in total

1.  [Soft tissue sarcoma of the upper extremities. Analysis of factors relevant for prognosis in 160 patients].

Authors:  M Lehnhardt; C Hirche; A Daigeler; O Goertz; A Ring; T Hirsch; D Drücke; J Hauser; H U Steinau
Journal:  Chirurg       Date:  2012-02       Impact factor: 0.955

2.  Intraoperative Ultrasound in the Treatment of Breast Cancer.

Authors:  H Eggemann; T Ignatov; A Beni; S D Costa; O Ortmann; A Ignatov
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-10       Impact factor: 2.915

3.  Intraoperative ultrasound-guided lumpectomy versus wire-guided excision for nonpalpable breast cancer.

Authors:  Xin Hu; Si Li; Yi Jiang; Wei Wei; Yinan Ji; Qiuyun Li; Zongbin Jiang
Journal:  J Int Med Res       Date:  2020-01       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.